Radiographic progression-free survival in the ACIS trial for prostate cancer reply

被引：0
|
作者：
Saad, Fred [1 ]
De Porre, Peter [2 ]
Brookman-May, Sabine [3 ,4 ]
Li, Jinhui [5 ]
McCarthy, Sharon A. [6 ]
Rathkopf, Dana E. [7 ,8 ]
机构：
[1] Univ Montreal, Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[2] Janssen Res & Dev, Beerse, Belgium
[3] Janssen Res & Dev, Los Angeles, CA USA
[4] Ludwig Maximilians Univ Munchen, Munich, Germany
[5] Janssen Res & Dev, San Diego, CA USA
[6] Janssen Res & Dev, Raritan, NJ USA
[7] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[8] Weill Cornell Med, New York, NY USA
来源：
LANCET ONCOLOGY | 2022年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E5 / E6
页数：2
相关论文
共 50 条
  • [31] Assessment of Patient and Clinician Perspectives on Clinically Meaningful Extension of Progression-free Survival in Prostate Cancer
    Oh, Ek Leone
    Huish, Wade
    El-Gamil, Sara
    Benson, Tim
    Ferguson, Thomas
    EUROPEAN UROLOGY OPEN SCIENCE, 2024, 70 : 175 - 182
  • [32] MRI radiomics predicts progression-free survival in prostate cancer (vol 12, 974257, 2023)
    Jia, Yushan
    Quan, Shuai
    Ren, Jialiang
    Wu, Hui
    Liu, Aishi
    Gao, Yang
    Hao, Fene
    Yang, Zhenxing
    Zhang, Tong
    Hu, He
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [33] Progression-free survival as a surrogate for overall survival in advanced cancer.
    Gillies, Eric
    Holdai, Veera
    Cowall, David Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M.
    Yelle, L.
    Lachaine, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 119 - 120
  • [35] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M. E.
    Yelle, L.
    Lachaine, J.
    VALUE IN HEALTH, 2012, 15 (07) : A414 - A414
  • [36] Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial
    Hrebien, S.
    Citi, V
    Garcia-Murillas, I
    Cutts, R.
    Fenwick, K.
    Kozarewa, I
    McEwen, R.
    Ratnayake, J.
    Maudsley, R.
    Carr, T. H.
    de Bruin, E. C.
    Schiavon, G.
    Oliyeira, M.
    Turner, N.
    ANNALS OF ONCOLOGY, 2019, 30 (06) : 945 - 952
  • [37] Progression-free survival is a surrogate of survival in maintenance therapy for metastatic breast cancer: Randomized trial level analysis
    Song, E.
    Yao, H.
    Yu, Y.
    Ou, Q.
    Wang, Y.
    CANCER RESEARCH, 2019, 79 (04)
  • [38] RADIOGRAPHIC PROGRESSION FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL AMONG MEN WITH METASTATIC CASTRATIONRESISTANT PROSTATE CANCER
    Maheshwari, V. K.
    Biswas, A.
    Chakravarty, A.
    Vanderpuye-Orgle, J.
    Pandey, P.
    Kondaparthi, P.
    VALUE IN HEALTH, 2023, 26 (12) : S24 - S24
  • [39] Panitumumab improves progression-free survival in metastatic colorectal cancer
    不详
    ONCOLOGY-NEW YORK, 2005, 19 (14): : 1800 - 1801
  • [40] Progression-free survival as a surrogate endpoint in advanced breast cancer
    Miksad, Rebecca A.
    Zietemann, Vera
    Gothe, Raffaella
    Schwarzer, Ruth
    Conrads-Frank, Annette
    Schnell-Inderst, Petra
    Stollenwerk, Bjoern
    Siebert, Uwe
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2008, 24 (04) : 371 - 383
12345